Provider review
Queen RX review
One GLP-1 product, sold by the quarter, listing three different active ingredients.
Three drugs of different potency are sold as one undifferentiated item at one price, with no dose and no monthly rung.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Queen RX
$299 per quarter, one GLP-1 product, no monthly rung
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The catalog is the story here. Queen RX sells one GLP-1 product and sells it as a quarter for a single charge, which means the number a reader wants — what a month of this costs — is not on the page and can only be produced by dividing. That division would be ours rather than theirs, so it does not belong beside their name. The three-month block also sits awkwardly against a reader whose plan is to try a small dose and see how they respond, since the whole quarter is bought before the first injection. Underneath that is a stranger gap. The medication safety section lists three different active ingredients for the one product on sale, and those are three drugs with different potencies, different dosing schedules and, at every other seller here, three different prices. Selling them as one undifferentiated item at one price means a buyer cannot know from the public site which molecule they are paying for, and therefore cannot work out what dose to hold or what a comparable product costs elsewhere. The claim of transparent pricing sits directly above that grid. It is accurate in the narrow sense that the one price shown is the price charged, and it is the opposite of informative about what the price buys. One customer review on the same page describes choosing between one-, three- and twelve-month supplies with no membership; if those options exist, the published catalog does not show them.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want one visible charge with no membership or fee stacked underneath it
- You have already settled on a quarter's supply and do not need a monthly option
- You want the price in front of you immediately, with no intake standing in the way
Look elsewhere if
- You want a monthly rate to compare. The only GLP-1 item is sold by the quarter
- You need to know which drug you are buying. One product carries three active ingredients
- You are trying a small dose first. The whole quarter is paid before the first injection
What it actually costs
Price as published
No monthly rate is published. The catalog holds exactly one GLP-1 item — "Compounded GLP-1 Treatment", labeled Quarterly, at $299 — alongside a $9 digital journal and a $29 hat · $299 buys three months, so a per-month figure would be one we divided rather than one they published · the safety copy lists three active ingredients for that single product — semaglutide, tirzepatide and liraglutide — and nothing published says which one a given order contains or whether the buyer chooses · the site advertises "transparent pricing, no hidden fees" beside the one-product grid · no dose is published · a customer review on the same page describes one-, three- and twelve-month supply options with no membership, none of which appear in the published catalog
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. The catalog holds exactly one GLP-1 item and it is sold by the quarter for a single charge, so a per-month figure would be one we divided rather than one they published. The safety copy lists three active ingredients for that one product — semaglutide, tirzepatide and liraglutide — which are three drugs of different potency sold as one undifferentiated item at one price, so a buyer cannot know from the public site which molecule they are paying for. No dose is published. The claim of transparent pricing above that grid is accurate about the charge and silent about what the charge buys. No low-dose product is offered. Recorded as an unnamed GLP-1 rather than under any single molecule: ONE product is sold and its safety copy lists three possible active ingredients, so listing it under semaglutide, tirzepatide or liraglutide would imply a buyer can choose which they receive, and nothing published says they can.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- The one price shown is a whole charge, with no membership or fee stacked beneath it.
- The catalog is small and the price is visible immediately, with no intake in the way.
- Compounding is stated to be done by licensed pharmacies, and branded products are not implied.
Pharmacy, labs and oversight
Queen RX does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What Queen RX publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The catalog is the story here. Queen RX sells one GLP-1 product, and it is sold as a quarter for a single charge, which means the number a reader would want — what a month of this costs — is not on the page and can only be produced by dividing. That division is ours, not theirs, so it does not belong beside their name. The three-month block also sits awkwardly against a reader whose plan is to try a small dose and see how they respond, since the whole quarter is bought before the first injection. Underneath that is a stranger gap. The medication safety section lists three different active ingredients for the one product on sale: semaglutide, tirzepatide and liraglutide. Those are three drugs with different potencies, different dosing schedules and, at every other seller here, three different prices. Selling them as one undifferentiated item at one price means a buyer cannot know from the public site which molecule they are paying for, and therefore cannot work out what dose to hold or what a comparable product costs elsewhere. The claim of transparent pricing sits directly above that grid. It is accurate in the narrow sense that the one price shown is the price charged, and it is the opposite of informative about what the price buys. One customer review on the same page describes choosing between one-, three- and twelve-month supplies with no membership; if those options exist, the published catalog does not show them.
The honest cons
The only GLP-1 product is sold by the quarter, so no monthly rate exists to compare.
- One product is listed with three different active ingredients and no way to tell which you get.
- No dose is published, so the quarterly charge cannot be matched to an amount of drug.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Queen RX is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#228 of 373
Ordered with the companies that pay us first, and Queen RX is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.